Home
Conditions
Lymphoma, Extranodal NK-T-Cell

Clinical trial condition

Lymphoma, Extranodal NK-T-Cell

Explore clinical trials studying Lymphoma, Extranodal NK-T-Cell. Study availability and eligibility vary by location and protocol.

157 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Extranodal NK-T-Cell trial results

Completed

Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma

NCT00897923

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +50 more
Locations: Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

NCT00416624

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +72 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Aurora Presbyterian Hospital Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States

View all 326 locations

View Trial Details

Completed

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

NCT00365768

Conditions: Burkitt Lymphoma, Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +55 more
Locations: Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, United States

View Trial Details

Completed

Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma

NCT01466881

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +23 more
Locations: Providence Hospital Mobile, Alabama, United States

The University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States

The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States

The University of Arizona Medical Center-University Campus Tucson, Arizona, United States

View all 161 locations

View Trial Details

Completed

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

NCT01748721

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +103 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Children's Hospital of Orange County Orange, California, United States

University of California San Francisco Medical Center - Parnassus San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

View all 20 locations

View Trial Details

Completed

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

NCT00161187

Conditions: Adenocarcinoma, Adnexal Diseases, Blast Crisis, +151 more
Locations: Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States

View Trial Details

Completed

Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies

NCT01658319

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +85 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant

NCT01959477

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +202 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma

NCT00561418

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +22 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Lymphoma, Extranodal NK-T-Cell

Lymphoma, Extranodal NK-T-Cell trial results

Related conditions